About Tempus Labs, Inc.
Tempus advances data-driven precision medicine through the practical application of AI in healthcare. It employs an analytical machine learning platform powered by artificial intelligence to derive insights from an extensive library of clinical and molecular data. By enabling physicians to make real-time, data-driven decisions, Tempus delivers personalized care and targeted therapies to patients. Tempus collaborates with partners in the healthcare industry, facilitating the discovery, development, and delivery of optimized therapeutic options across various medical domains. Specializing initially in oncology and expanding to neuropsychiatry, cardiology, infectious disease, and radiology, Tempus remains committed to its mission of improving patient outcomes by providing tools that leverage accumulated data.
Tempus Stock Price
Trailing performance
Quarterly performance
Tempus Valuation
Frequently Asked Questions
Does Tempus have stock?
Yes. Tempus is a private venture-backed company. Investors usually purchase preferred stock and employees typically receive common stock options or restricted stock units (RSUs) as part of their compensation.
What is Tempus's stock symbol?
Since it is not publicly listed, there is no Tempus stock symbol or Tempus ticker symbol assigned for Tempus.
Private companies typically reserve a stock symbol up to two years prior to an IPO, and disclose this when they file a Form S-1 with the Security Exchange Commission when they start the IPO process.
How can I sell Tempus stock?
If you own shares of a private company, it may be possible to find liquidity for your holdings before the company goes public. Finding the right private market broker can make all the difference as the best brokers can leverage deep industry relationships and negotiate on your behalf.
If you are interested in selling private stock you can reach out to Premier brokers for more information.
How do Tempus pre-IPO trades work?
Private market transactions can be complex and may involve company approvals, legal purchase agreements and wires to third parties. Trades can take 30 - 60 days to complete which is why many investors work with experienced private market brokers to help guide the process.
Direct share transfers typically require issuer approvals. Issuers may exercise the right of first refusal (ROFR) in order to direct the seller to a buyer of their choosing.
Some issuers do not allow transactions. In these cases, buyers will need to purchase indirect interests in the business via special purpose vehicles (SPVs) or forward purchase contracts (forwards).
Is Tempus publicly traded?
Tempus stock does not trade publicly on Nasdaq or NYSE because it is still a private company. Tempus stock might be available for purchase in the secondary markets, but Tempus stock is not available for purchase by the general public, and can not be purchased through traditional brokerage accounts.
How can I buy Tempus stock?
Only accredited investors and qualified purchasers can buy private stock. These investors buy pre-IPO stock in the secondary market from existing employees and investors.
To learn more about the market for Tempus stock, talk to the best brokers on the planet.
How to invest in Tempus?
Accredited investors can purchase shares in private companies like Tempus. Investors can rely on Notice Premier Brokers to find supply and guide them through the trading process.
Because Tempus is privately held, its stock is not available for purchase through public stock exchanges like the NYSE or Nasdaq. Retail investors can not access this stock via traditional brokerage accounts, and are not allowed to invest directly in Tempus pre-IPO.
Popular companies
